Portfolio company
Emulsi Biotech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Emulsi Biotech develops lipid-based oral drug delivery platforms to enable pharmaceutical companies to administer complex biological therapies through capsules instead of injections.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Biograil
This biotech company develops a capsule device that enables oral delivery of injectable biologic drugs for pharmaceutical firms and patients.
Exolvo Biosciences
Exolvo Biosciences develops oral smart capsules for the delivery of biologic drugs to pharmaceutical companies and patients.
Exolvo
This company develops smart capsules using dissolvable microneedles for the oral delivery of biologic drugs to pharmaceutical partners and patients.
SEncIL
SEncIL develops encapsulation technology that transforms liquid drugs into polymer-encapsulated powders to improve oral drug delivery for pharmaceutical companies.
Nexos
Nexos Biosciences develops exosome-based drug delivery systems for pharmaceutical companies to enable oral administration of treatments for cancer, inflammation, and metabolic diseases.
Surf Bio
This company develops drug stabilisation and delivery platforms for pharmaceutical manufacturers to enable high-concentration subcutaneous administration of biologics and vaccines.
Disruptive Pharma
This company develops a drug formulation platform to improve the solubility and bioavailability of pharmaceutical compounds for the healthcare industry.
Hone Bio
This company develops lipid nanoparticle targeting technology for pharmaceutical and biotechnology firms to enable precise drug delivery beyond the liver.
